Diabetes Mellitus (DM)
14
0
3
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
14.3%
2 terminated out of 14 trials
66.7%
-19.8% vs benchmark
14%
2 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Evaluating the Efficacy of Pulsating Electromagnetic Field Therapy by CRAD ULCER X-01 for Diabetic Foot Ulcers
This Study is Conducted to Evaluate the 18-month Clinical Performance of Complete Bioactive Restorative System for Occlusal Restorations Between Diabetic and Non-diabetic Patients.
Evaluation of the Psychometric Properties of the Turkish Version of the Hypoglycaemia Self-Care Behaviour Scale
Central Sensitization in Painful and Painless Diabetic Peripheral Neuropathy
Effect of Golden Rice-Piper Crocatum Cookies on Neuropathy Prevention in Diabetes
Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients
Improving the Activation Level of Diabetic Individuals
Metatarsal Phalangeal Joint Deformity Progression - R01
The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
Continuous Glucose Monitoring for Personal Protective Equipment Evaluation
Post ACA Reform: Evaluation of Community Health Center Care of Diabetes
The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
Expanding Paramedicine in the Community
Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM